Acorda Calls for 2 More Trials
Motley Fool - USA
On Friday, Acorda updated investors on the progress of its MS drug, named Fampridine-SR. As expected, the FDA is requiring another phase 3 trial of the drug ...

Acorda Therapeutics Provides Update on Clinical Development of ...
PharmaLive.com (press release) - Newtown,PA,USA
Acorda's lead clinical stage product, Fampridine-SR, recently completed a Phase 3 study in people with MS. The Company's pipeline includes a number of ...

Improved Quarter for Biotech on Capital Markets ... and Financings ...
Yahoo! News (press release) - USA
Its shares took off in September after it had announced that its Phase III trial on Fampridine-SR its multiple sclerosis treatment, improved patients' ...